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1. Introduction 
At the pre-implantation blastocyst stage of development, the mammalian embryo is 
composed of a unique collection of cells of which three major populations predominate. The 
outermost layer the trophectoderm (TE) gives rise to the placenta, which acts to sustain the 
developing fetus connecting it to the mother host. The next is a cluster of cells known as the 
inner cell mass (ICM) these cells are said to be pluripotent (Fig. 1). A third group of cells 
known as the primitive endoderm, surrounds the ICM cells at the epiblast stage. As 
development proceeds the ICM cells rapidly divide and eventually begin to differentiate 
forming the three embryonic germ layers (ectoderm, mesoderm and endoderm). Effectively 
these pluripotent ICM cells are the precursors of all adult tissues. As these pluripotent cells 
commit to a specific cellular lineage, they lose their pluripotency. Embryonic stem (ES) cells 
are euploid pluripotent cell lines isolated directly from cultured preimplantation embryos. 
The first stable ES cell lines were isolated by immunosurgery from the ICM of implantation-
delayed, mouse blastocysts (Martin, 1981; Evans and Kaufman, 1981). Mouse ES cells are 
very closely related to early ICM cells in terms of their developmental potential (Beddington 
and Robertson, 1989). This chapter will focus on mouse ES cells (mES) unless otherwise 
stated. Three features characterize mES cells; 
1. They are isolated directly from the embryo (Robertson, 1987). 
2. They can colonize the germ line when introduced to the embryo. 
3. They possess unrestricted proliferative potential (Suda et al., 1987). 
These features effectively mean that under appropriate conditions, a karyotype stable self-
renewing, pluripotent population of cells can be propagated indefinitely in vitro. mES cells 
have other characteristics, which prove useful when comparing embryo derived stem cells 
to their differentiated progenies. mES cells have a euploid (2n) chromosome complement, a 
feature that allows their participation in germ cell development and the formation of 
chimeras (Bradley et al., 1984; Evans, 1994). The functional demonstration of mES cell 
developmental potential through chimera formation is the definitive proof of the 
pluripotent nature of the cell population in question. Biomarkers are often used as indicators 
of the stem cell state due to the time consuming and technically more difficult nature of 
getting functional proof of stemness. Many of the common markers are transcription factors 
expressed in the ICM and mES cells and have been shown to have functional roles in self-
renewal and in the maintenance of pluripotency, in both isolated stem cells or the ICM. The 
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surface markers expressed depend on species of origin, but common markers include 
members of the stage specific embryonic antigen (SSEA) family, alkaline phosphatase and 
Oct4 (Andrews, 2002; Pera et al., 2000; Shamblott et al., 1998). SSEA-1 is expressed in mouse 
preimplantation embryos from the eight-cell stage until the embryo differentiates into germ 
layers when it remains only in the ectodermal lineage (Solter and Knowles, 1979; Resnick et 
al., 1992; Pelton et al., 2002). Some of the best-characterized examples include the POU 
domain transcription factor Oct4, the homeodomain protein Nanog and the high-mobility 
group transcription factor Sox2. Of the three factors mentioned our understanding of Oct4 is 
best developed. Oct4 deficient embryos fail to initiate fetal development, indicating that 
Oct4 is essential for embryo development (Nichols et al., 1998). In mES cells there is an 
altered level of expression upon differentiation, a profile for down-regulation into TE and 
up-regulation in endoderm correlates with the Oct4 profile of expression in vivo embryos 
(Palmieri et al., 1994). mES cells can be maintained in an undifferentiated state in vitro with 
relative ease. They represent pluripotent embryonic cells, which are present only transiently 
in vivo. This enables their use as an in vitro model to elucidate the mechanisms of 
differentiation that these pluripotent cells undergo in vivo. The regulatory signaling and 
transcription networks that play a role in pluripotency and self-renewal it would seem have 
been conserved between mouse and human ES (hES) cells, however many differences also 
are found. As distinct from mES cells, hES cells do not appear to express high levels of 
SSEA1, but do have high levels of SSEA-3, −4, TRA-1–60 and TRA-1–81 (Brimble et al., 2007; 
Reubinoff et al., 2000). Other difference also exist, both cell types have a high ratio of nuclear 
to cytoplasmic volume, mES cells grow in nests and form three dimensional embryoid 
bodies while hES cells often grow in colonies as thin layers. Furthermore hES cells unlike 
mES can be maintained in a self-renewal cycle in the absence of the cytokine LIF or a feeder 
layer. Recently a population of cells with pluripotent capability was isolated from a post-
implantation mouse epiblast at the later stages of development (Brons et al., 2007; Tesar et 
al., 2007). These epiblast stem cells (EpiS cells) do not require LIF support as ICM derived 
mES cells do (Rossant, J. 2007; Nagy et al., 2003). Morphologically EpiS cells are more like 
hES cells than mES cells as they tend to grow as thin flat layers. Considering these difference 
and others, the idea that mES and hES cells while both pluripotent, may in fact represent 
different and distinct stages in development.  
Early studies with mES cells showed that the use of mitotically inactivated STO cells (Ware 
and Axelrad, 1972; Hooper, 1997) was essential in the maintenance of self-renewal and the 
pluripotent state. Later it was found that the requirement for the feeder layer could be 
circumvented by the addition of the cytokine LIF in the presence of serum. In the absence of 
feeder layers or LIF, mES cells differentiate into a variety of cell types (Doetschman et al., 
1985) depending on the developmental cue or signaling pathway activated. The process of 
differentiation can be seen as a loss of pluripotency and mES like their in vivo counterparts 
are capable of multi-lineage differentiation. mES cells undergo a controlled pattern of 
differentiation when injected and reintegrated into a pre-implantation blastocyst. Under 
these circumstance mES cells respond as ICM cells to in vivo differentiation cues and fully 
participate in normal development. Furthermore they are capable of forming a wide range 
of normal cells including germ cells (Bradley et al., 1984; Robertson et al., 1986). In vitro mES 
cells can be induced to differentiate, by culturing cells in suspension or in a monolayer 
system under the effect of chemical inducers such as retinoic acid (Robertson, 1987). When 
mES cells are propagated under conditions that discourage their attachment to the 
substratum they form small aggregates, termed embryoid bodies (EBs). These three 
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dimensional colonies organize in such a way that an endodermal layer develops on the 
outer surface and are now known as "simple embryoid bodies". The inner stock of cells 
remain undifferentiated not unlike the early events of embryogenesis, where the 
trophectoderm differentiates from the peripheral cells of the morula, while the inner cells 
remain pluripotent.  
 
 
Fig. 1. Key transcription factors involved in self-renewal of ES cells. 
Differentiated mES cells from EBs can give rise to a wide variety of cell types including 
neuronal (Bain et al., 1995), hematopoietic (Suwabe et al., 1998), endothelial (Yamashita et al., 
2000), cardiac (Maltsev et al., 1993), smooth muscle (Yamashita et al., 2000), chondrogenic 
(Kramer et al., 2000) and osteoblastic cells (Buttery et al., 2001). For stem cells there is a 
constant balancing act that must be maintained between self-renewal and the pluripotent 
phenotype versus cell lineage commitment and differentiation. 
An understanding of the pathways and controlling factors involved in these fundamental 
cellular events is essential if we are to exploit the full potential of embryo derived stem cells 
for therapeutic uses in disease treatments and regenerative medicine in the future. This 
potential is real as it is clear that embryo derived stem cells are capable of unlimited self-
renewal capacity and can differentiate into potentially any of over 200 cell types. The 
potency of these cells is maintained by a number of key regulatory factors, signaling 
pathways and extracellular signaling agents. The combination and interplay of these 
elements establishes a patterns of gene expression that sustains the pluripotent phenotype of 
ES cell. Some of the key regulators are transcription factors such as Oct4, Sox2 and Nanog, 
the signaling cascades involving phosphatidylinositol 3-kinase (PI3K) and the signaling 
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molecules like LIF and Wnt proteins. Embryonic stem cells have great therapeutic potential 
however to fully realize the potential of these cells the signaling pathways that participate in 
controlling ES cell behavior must be better understood.  
2. Pluripotency and Self-renewal 
 In the developing embryo, pluripotent cells first appear in the ICM, in the mouse blastocyst 
this is approximately at day 3.5 of embryonic development (E3.5). These cells persist as late 
as the pre-gastrulation stage. Thus in vitro mES cells represent a very transient population of 
cells existing for a very short period of time in vivo. Experimental extraction of these cells 
facilitates the expansion and maintenance of the pluripotent state in vitro. mES cells are 
pluripotent, which is defined as the ability to differentiate into all cell lineages that make up 
the adult organism (Buehr et al., 2003). Functional assessment of the pluripotency of mES 
cells can be determined by the capability of the cells to reintegrate, into the ICM of E3.5 
blastocysts contributing to all cell lineages. Strict pluripotency has been shown only in the 
mouse, where mES cells completely integrate producing a high rate of chimerism in all 
tissues. In the presence of fetal serum, activation of STAT3 by LIF is sufficient to maintain 
mES cells in an undifferentiated state (Williams et al., 1988; Matsuda et al., 1999) however, 
this is not the case for hES cells (Dahéron et al., 2004). Potentially parallel pathways are at 
play in mouse and human ES cells through which ES cells achieve similar end points and 
sustain pluripotency. This characteristic is sustained by the ability of ES cells to self-renew. 
ES cells are capable of differentiation but also symmetrical division generating two identical 
undifferentiated pluripotent daughter cells. In real terms mES cells can be expanded 
indefinitely (years) in a self-renewal cycle, once culture conditions prevent differentiation. It 
appears that maintaining a pluripotent state during mES cell self-renewal is through active 
suppression of differentiation and the promotion of proliferation. The differentiation of mES 
cells can be induced by the ectopic expression of certain transcription factors. Forced 
expression of Gata6 in mES cells drives differentiation toward primitive endoderm lineages 
(Fujikura et al., 2002), while increasing Cdx2 results in trophectoderm formation (Niwa et 
al., 2005). Thus, the expression of genes promoting self-renewal, cell proliferation and 
suppressing cellular differentiation pathways must be stably maintained and passed on to 
each daughter cell. The regulation of self-renewal is of great interest and importance in 
developing our basic understanding but also for the development of regimes for cellular 
therapy. The ability to control and maintain the expansion of pluripotent cells is a 
cornerstone, if the true clinical potential of ES cell-derived therapies is to be realized for 
regenerative medicine. mES (Martin, 1981) and hES (Thomson et al., 1998) cells are similar in 
this regard although not absolutely identical, the molecular machinery and pathways 
involved is equally complex but involves a number of distinct players in each case (Sato et 
al., 2003). A good example of this is the vitamin A metabolite, all-trans-retinoic acid which 
has the effect of silencing self-renewal and driving a differentiation agenda for both mES 
and hES cells lines (Chen and Gudas, 1996; Mongan and Gudas, 2007). The self-renewal 
pathways in ES cells comprise complex networks of strategic actions of extracellular agents 
(including the presence or absence in culture of serum), intracellular signaling pathways 
and the control of key transcription factors. In vitro, LIF supports self-renewal and 
pluripotency of mES cells through activation of STAT3 (Smith et al., 1998), removal of LIF or 
suppression of STAT3 results in differentiation (Niwa et al., 1998). LIF receptor knockout 
mouse embryos are capable of passing the developmental stage required for mES cell 
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derivation. Thus in vivo it is obvious that there is no magic bullet but other factors are also 
involved in this process (Nichols et al., 2001). The cytokine LIF was among one of the 
earliest molecules found to be associated with the maintenance of stem cell self-renewal in 
vitro and in vivo. More recently other factors have become known including the bone 
morphogenetic proteins (BMPs) 2 and 4 and glycogen synthase kinase-3. Under serum free 
culture conditions, mES cells require the presence of both LIF and BMPs to facilitate 
continued self-renewal (Ying et al., 2003). It appears that linked pathways are at play, LIF 
supporting self-renewal and proliferation, while BMP4 up-regulates members of the Id gene 
(inhibition of differentiation) family (Ying et al., 2003). Signaling pathway crosstalk with 
PI3K signaling has also been shown to play a part in self-renewal. The transcription factors 
Oct4, Sox2, and Nanog are now widely accepted as having a central role in promoting self-
renewal and sustaining the undifferentiated phenotype (Ying et al., 2003). As if to 
emphasize the reliance of self-renewal on networked interactions, recent work has shown 
that a key set of promoter sequences bind Oct4, Sox2, and Nanog in ES cells (Chambers and 
Tomlinson, 2009; Avilion et al., 2003; Masui et al., 2007; Niwa et al., 2005). This however is 
not the total picture as further extensions of the co-dependence of the self-renewal network 
is coming to light all the time, interestingly some of these newer interactions are 
independent of the established tri-umbret of Oct4, Sox2, and Nanog (Ivanova et al., 2006). 
Other work is providing evidence to suggest that two independent pathways may be as 
play in ES cells. The established Oct4, Sox2, and Nanog networks may be acting to suppress 
differentiation and thus sustain pluripotency. While other transcription networks play a role 
in repression of specific cell lineage differentiation. Further extension of these 
interconnecting pathways includes the addition of the role of miRNA-encoding genes 
(Marson et al., 2008). In the following sections the role of specific transcription factors and 
signaling pathways will be expanded upon in the context of their role in the self-renewal of 
ICM derived mES cells.  
2.1 Transcriptional networks 
2.1.1 Oct4 
Oct4 is a member of the POU (Pit-Oct-Unc) transcription factor family that regulates the 
expression of target genes by binding to a octameric sequence (Scholer et al., 1990). The key 
features of this family are the POU domain consisting of two sub-domains each of which 
bind to DNA. However the C-terminal is cell specific and may be essential for the 
expression of target gene in an orderly fashion as embryonic development proceeds. It is 
well established that the Oct4 gene (encoded by Pou5f1) is constitutively expressed in 
undifferentiated mES cells, in all pluripotent cells during mouse embryo development and 
is also an essential factor required in the generation of iPS cells (Niwa et al., 2000). Oct4 is 
also known as Oct3, Oct3/4, Otf3, and Otf4. In the mouse, Oct4 expression is up regulated 
beginning at the 4-cell stage and becomes localized to the pluripotent cell population (Yeom 
et al., 1996). The expression of Oct4 is common to human and mouse ES cells, and 
furthermore expression diminishes in both as cells differentiate. In vivo Oct4 knockout 
mouse embryos crash and do not develop beyond the blastocyst stage, they lack a 
pluripotent ICM cell population (Nichols et al., 1998), strongly suggesting a central role for 
Oct4 in maintaining pluripotency. In cells were Oct4 is repressed or in Oct4 knockouts, mES 
cells differentiate towards a trophoectodermal lineage. It has been reported that Oct4 
inhibits trophectoderm lineage formation via an interaction with Cdx2 forming of an 
inhibitory complex (Niwa et al., 2005). Conversely up regulation or over-expression of Oct4 
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results in mES cell moving towards primitive endoderm (Niwa et al., 2000). These divergent 
effects of Oct4 suggest that it regulates the transcription of genes involved in coordination of 
multiple cellular functions and early cell fate decisions. Thus the actual level of Oct4 
expression is important and a key level of expression is required to sustain pluripotency and 
self-renewal. In mES cells the expression of Oct4 is supported by the action of LIF and down 
regulated by the chemical inducer all-trans retinoic acid (Faherty et al., 2005; 2007). 
Suppression of STAT3 and accelerated expression of Oct4 also causes mES cells to 
differentiate (Niwa et al., 1998; Niwa et al., 2000). The role is Oct4 as a so called master 
regulator in sustaining pluripotency and self-renewal of mES cells is well known, however it 
is not a solo run (Nichols et al., 1998; Boyer et al., 2005). Oct4 alone without LIF, is not 
sufficient to sustain self-renewal and prevent mES cell differentiation, suggesting that 
additional factors also play a part. More recently it has been shown that Oct4 expression 
prevents stem cell differentiation by sustaining the expression of other pluripotency factors 
and inhibiting gene expression of lineage specific factors. Known targets for Oct4 include 
Fgf4, Rex1/Zfp42, and Sox2 (Zeng et al., 2004; Tomioka et al., 2002). Oct4 has been shown to 
act in concert with other factors and its DNA binding often occurs in conjunction with the 
HMG-family protein Sox2, an additional factor required for maintaining mES cell stemness 
(Chambers and Smith, 2004; Pesce and Schöler, 2001). Oct4 is a key regulator of ES cell fate, 
particularly in maintaining a pluripotent state. The requirement appears to be that Oct4 
protein levels are constrained within the narrow band. It is clear that Oct4 has a critical role 
in sustaining pluripotency, however its control is unclear. The control of the level of 
expression appears somewhat auto-regulatory (Chew et al., 2005), but also depends on other 
factors including the transcription factor Nanog providing a feedback loop to sustain self-
renewal (Pan et al., 2006) 
2.1.2 Nanog 
Nanog is an homeobox containing transcription factor of approximately 280 amino acids. In 
the developing mouse embryo Nanog plays a key role in determining the fate of the ICM 
cells, acting to sustain pluripotency and preventing differentiation (Chambers et al., 2003). 
Nanog was identified as a factor, which when over expressed, supported pluripotency even 
in the absence of a LIF based signal. In the embryo Nanog expression is first seen at the 
compacted morulae stage before becoming restricted to the ICM, post-implantation stage 
Nanog expression is drastically reduced. In vitro, Nanog expression is abundant in 
pluripotent cell types but absent from adult tissues (Chambers et al., 2003). As with their in 
vivo counterparts upon differentiation of mES cells the expression of Nanog is 
downregulated. Nanog-null embryos fail soon after implantation, stem cells derived from 
such embryos are pluripotent but are found to quickly differentiate (Chambers et al., 2003; 
Mitsui et al., 2003). Over-expression of Nanog without any other intervention is sufficient to 
sustain self-renewal even without LIF albeit the self-renewal capacity under these conditions 
is reduced. Under the same conditions the level of active STAT3 is not appreciably altered, 
furthermore increased STAT3 signaling does not appear to alter Nanog expression. These 
data would suggest that Nanog is neither a target for STAT3, or does it regulate STAT3 
activity. However at one least report suggests Nanog is a direct downstream target for 
STAT3 in the maintenance of pluripotency (Suzuki et al., 2006). BMP signaling normally acts 
during embryonic development to induce mesoderm formation, but effects in mES cells can 
be quite different (Winnier et al., 1995). In mES cells low levels of BMPs in the absence of LIF 
promote mesoderm, while in the presence of LIF, mES cell pluripotency is sustained (Ying et 
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al., 2003). BMP signaling is facilitated by downstream effectors including SMAD1, an 
effector which Nanog has been shown to interact with and leads to inhibition of BMP 
signaling (Suzuki et al., 2006). What is being proposed is that BMPs are at least initially pro-
mesoderm lineage formation as evidenced by up-regulation of Brachyury a mesoderm 
marker. When activated STAT3 interacts with Brachyury and increases Nanog expression, 
the elevated levels of Nanog inhibit BMPs via SMAD1 interaction and thus maintain the 
undifferentiated pluripotent state. Nanog is now accepted as an important component in 
regulating the pluripotent phenotype however the mechanism of its own control and how it 
effects other genes is not entirely elucidated. It has been shown that Oct4 and Sox2 can bind 
to the Nanog promoter in vitro and in vivo (Rodda et al., 2005) suggesting that Oct4/Sox can 
act to up regulate Nanog expression. However other studies have shown that Nanog 
expression can be maintained in the absence of Oct4, thus other factors must contribute to 
the regulation. One such factor is a member of the forkhead family FoxD3, which is found in 
mES cells and the early embryo. FoxD3 knockout embryos have a similar fate as Nanog 
knockouts (Hanna et al., 2002). The exact mechanism by which Nanog is regulated and how 
it effects control of mES cell pluripotency is unknown, however it appears independent of 
STAT3 activation or the requirement for BMP4 at least when in serum free culture 
conditions. Nanog is capable of activating the Oct4 promoter forming a negative feedback 
loop upregulating Oct4 at times and suppressing Oct4 when levels are above normal (Pan et 
al., 2006). Furthermore it has been shown that Nanog is capable of activating Rex1 a target 
for Oct4 and Sox2 (Shi et al., 2006). Furthermore it has also been suggested that Nanog may 
interact with Wnt and BMP4 signaling independent of LIF which may help explain why the 
forced expression of Nanog in the absence of LIF sustains a level of self-renewal (Chambers 
et al., 2003; Mitsui et al., 2003). The regulation and comprehensive elucidation of the role of 
Nanog requires more experimental work before we can paint a true picture of its overall role 
in pluirpotency. 
2.1.3 Sox2  
Sox2 is a DNA-binding protein of the HMG family. In the mouse Sox2 is expressed 
predominatley at the blastocyst stage (Avilion et al., 2003). However unlike Oct4, Sox2 has a 
major role to play also later in development and in adult stem cells (Wood and Episkopou, 
1999; Zappone et al., 2000). At early stages of development and in mES cells, Sox2 activates 
target genes through interaction with Oct4. Sox2 knockouts are lethal to mouse embryos and 
they fail to fully develop, furthermore ES cells derived from these embryos are unable to 
proliferate or self-renew (Avilion et al., 2003). As outlined for Oct4, a precise level of Sox2 
appears to be key for pluripotency and to sustain self-renewal. Many studies have 
highlighted how Oct4 and Sox2 can in a direct way drive the expression of genes required 
for pluripotency including positive feedback on their own expression and that of Nanog 
(Chew et al., 2005; Tomioka et al., 2002). Together with the transcription factor Klf4, they 
activate the expression of Lefty1 (Nakatake et al., 2006). In mES cells a wide range of studies 
have focused on and delineated the functional role of Oct4, less is known about Sox2. Recent 
studies are beginning clear up the role of Sox2. As might have been anticipated mES cells 
deficient in Sox2 lose pluripotency and quickly differentiate supporting the perceived role of 
Sox2 in maintaining self-renewal. What is interesting is that in the Sox2 protein deficient 
system Oct-Sox enhancers are still active and up-regulation of Oct4 alone is sufficient to 
rescue these cells from differentiation. Thus it has been suggested that potentially other 
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members of the Sox family may substitute for Sox2 in the co-activation process mediated in 
partnership with Oct4. What has become clear is that Sox2 plays a role in regulating many 
transcription factors that can affect Oct4 levels including Nanog. Furthermore in cellular 
reprogramming studies up-regulation of Oct4 in combination with Sox2 is sufficient to 
generate pluripotent cells (Takahashi and Yamanaka, 2006; Okita et al., 2007). Some 
fascinating studies looking at global protein phophorylation patterns in hES cells have 
revealed some interesting dynamics in the Oct4 and Sox2 pattern of activation (Burdon et 
al., 2002). Thus exploring phophorylation pathways from extracellular signals to gene 
transcription effects will be key to furthering our understanding of self-renewal, in this 
context, pathways like those involving LIF and PI3K will be key to disentangling the 
signaling and transcription circuits involved. 
3. Signal transduction pathways 
3.1 Leukemia inhibitory factor (LIF) 
LIF is expressed in mouse preimplantation embryos from fertilization to the blastocyst stage 
but not in TE cells (Nichols et al., 1996). LIF transcripts are also found in mES cells (Rathjen 
et al., 1990) and endometrial glands of the mouse uterus which stops once implantation has 
occurred. Mouse LIF gene knockouts result in growth retardation and fertilized blastocysts 
fail to implant (Stewart et al., 1992). Historically mES cells were derived and maintained on a 
feeder layer of embryonic fibroblast. Subsequently it was found that the use of conditioned 
media from these fibroblast cultures was sufficient to maintain mES cell self-renewal. It was 
then shown that a the active agent produced by the feeder layer capable of blocking mES 
cell differentiation was in fact a cytokine later identified as leukemia inhibitory factor (LIF) 
(Smith et al., 1988). LIF is the best-characterized effector of self-renewal in mES cells. It is a 
multifunctional cytokine, which has a wide variety of effects on various cell types (Hilton 
and Gough, 1991). The name LIF is based on initial observations that in vitro it is capable of 
inducing irreversible differentiation of the murine leukemia cell line M1 to macrophages. 
LIF is a highly glycosylated single chain polypeptide and a member of IL6 cytokine family 
(Taga and Kishimoto, 1997). LIF is known to be secreted by a number of cell types including 
fibroblasts, lymphocytes spleen and liver cells (Gough and Williams, 1989). LIF is a very 
potent agent, in vitro 10-9g/L-1 (defined as 50U/mL-1) induces approximately 50% of a 
population of M1 cells (murine leukemia cell line) to differentiate. LIF induces a wide 
variety of effects on different cell types e.g. LIF has been shown to sustain the survival of 
murine primordial germ cells (DeFelici and Dolci, 1991) and stimulate the proliferation of 
myoblasts in culture. It has also been shown to affect bone growth and remodeling in vitro 
(Lorenzo et al., 1990; Wilson et al., 1992; Gearing et al., 1992; Ip et al., 1992; Taga and 
Kishimoto, 1997).  
The cellular actions of LIF are effected via a specific cell membrane receptor. The LIF 
receptor is a heterodimeric complex composed of a glycoprotein subunit gp130 and the 
receptor subunit LIFR (also called LIFRβ) (Ernst and Jenkins, 2004). Studies in mES have 
shown that the gp130 subunit is the essential component in transmitting self-renewal signals 
(Nakamura et al., 1998). Binding of LIF to the LIFR subunit induces dimerization with gp130, 
resulting in the formation of a high affinity receptor complex. The activated receptor 
switches on the constitutively bound tyrosine kinase Janus kinase (JAK). Activated JAK, 
phosphorylates both receptor subunits forming SH2 domain bind sites, which are capable of 
recruiting other signal transduction partners.  
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The SH2 domains facilitate the binding of signal transducers and activators of transcription 
(STAT) 1 and STAT3, which are phosphorylated by JAKs (Stahl et al., 1995). The activated 
STAT proteins form homodimers or heterodimers which then move to the nucleus, where 
they act as transcription factors (Auernhammer and Melmed, 2000). STAT3 is the principal 
STAT protein activated in mES cells stimulated with LIF (Niwa et al., 1998). Activation of 
STAT3, has been shown to be critical for LIF/gp130 dependent self-renewal in mES cells 
(Niwa et al., 1998). Using a tamoxifen inducible form of STAT3 (fusion of STAT3 to estrogen 
receptor) it has been shown that activation of STAT3 is capable of sustaining self-renewal of 
mES in the presence of serum (Mastuda et al. 1999).  
In the absence of fetal calf serum, in the presence of activated STAT3, BMP4 signaling 
maintains pluripotency. However, for hES cells LIF-STAT3 signaling cannot maintain 
pluripotency (Reubinoff et al., 2000) additional factors independent of LIF-STAT3 are 
required including basic fibroblast growth factor (bFGF) in the presence of Noggin which 
acts as a BMP pathway inhibitor. The exact mechanism of LIF-STAT3-dependent mES cell 
self-renewal is still not fully elucidated although models are arising (Fig. 2). A notable target 
for STAT3 is the transcription factor Myc (Cartwright et al., 2005) which along with others 
(Klf4, Oct4 and Sox2) has a role in cellular reprograming of somatic cells to a pluripotent 
state (Takahashi and Yamanaka, 2006). The forced up regulation of Myc supports self-
renewal in the absence of LIF. Whereas cessation of LIF signaling results in a decrease in 
Myc expression presumably through a down-regulation of STAT3. Apart from the above-
mentioned STATs a wide range of other downstream effector molecules can be activated 
through LIF receptor activation including extracellular regulated kinases (ERK), mitogen-
activated protein kinases (MAPK) and phosphatydilinositol-3 kinase (PI3K). The network of 
interactions between intracellular pathways and extracellular ligands continues to develop a 
pace, with numerous overlaps being identified. In this context another kinase, glycogen 
synthase kinase 3 (GSK3) a key enzyme in the Wnt pathways is quickly activated resulting 
in Myc phosphorylation and its degradation. The activity of GSK3 may be controlled by 
PI3K either directly or indirectly due to LIF signaling. Another possible network connection 
is that between LIF, PI3K and the Wnt pathway in self-renewal comes from the data that 
shows improved results in the derivation of mES cells in the presence of the GSK3 inhibitor 
BIO. Thus from a signaling perspective multiple pathways may be involved in the 
maintenance of low levels of GSK3 activity to promote pluripotency and mES cell self-
renewal. The array of signaling pathways and the level of crosstalk that exist between them 
and the LIF-STAT3 pathway in mES is slowly being deciphered giving us a clearer picture of 
the connections between LIF signaling and the transcriptional machinery controlling self-
renewal. 
3.2 PI3K Pathway 
Phosphatidylinositol 3 kinases (PI3Ks) are recognized to modulate a wide range of cellular 
functions from growth, proliferation and self-renewal to simple metabolic control. They are 
a family of enzymes, which phosphorylate the 3′-OH position of the inositol ring of 
phosphoinositides. In 1987 (Whitman et al., 1987) identified two distinct 
phosphatidylinositol kinases (PIKs) isolated from fibroblasts. They further demonstrated 
that one of these enzymes associated with activated tyrosine kinase receptors. They called 
this kinase type I PIK. Subsequently the same group showed that the most abundant form of 
the previously identified enzymes, type II PIK, phosphorylates the D-4 position on the 
inositol ring and that type I PIK phosphorylated the inositol ring at the D-3 position. 
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Fig. 2. LIF signal pathways and it integration into transcription machinery of self-renewal. 
Adapted from Niwa et al., 2009 
Currently the family is divided into 3 classes based on structure and substrate preference 
(Wymann and Pirola, 1998; Vanhaesebroeck et al., 2001). Class I PI3Ks form heterodimers, 
consisting of a ∼110 kDa catalytic subunit, and a regulatory subunit. The regulatory subunit 
comes in 4 main flavours (p85a, p55a, p50a, p85b, p55g) and a catalytic subunit in 3 major 
types (p110a, p110b, p110d) (Engelman et al., 2006). In vivo the primary substrate is 
phosphatidylinositol-4,5, bisphosphate (PtdIns(4,5)P2 or PIP2), which is converted to 
phosphatidylinositol-3,4,5, triphosphate (PtdIns(3,4,5)P3 or PIP3) (Cantley, 2002). This class 
of PI3Ks are activated by an array of plasma membrane receptors (for a review see Wymann 
et al., 2003). Class II PI3Ks produce PI(3)P and PI(3,4)P2 in vitro, but in vivo targets are less 
clear but the enzyme itself has been localized to the Golgi network. Class III PI3Ks produce 
only PI(3)P. Much of what we know about the functions of PI3K is because a potent and 
quite specific inhibitor is available. Wortmannin and LY294002 act as competitive ATP 
binders targeting the ATP-binding site of catalytic p110 subunit. The most interesting early 
finding was that wortmannin in the low nanomolar range blocked the respiratory burst of 
neutrophils (Baggiolini et al., 1987). Studies on purified enzymes have shown that the 
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mammalian PI3K is the most sensitive to wortmannin (Yano et al., 1993). The use of these 
inhibitors has proved invaluable in the study of PI3K and its cellular effects (reviewed by 
Nakanishi et al., 1995). The best known product of PI3K action is PIP3 which has been 
shown to be an important second messenger capable of recruiting AKT and involved in 
numerous cellular pathways associated with growth, proliferation and survival (Cantley, 
2002). The production of PIP3 facilitates the recruitment of pleckstrin homology (PH) domain 
containing proteins an important example of which is the protein kinase Akt which itself has 
multiple intracellular targets (Toker, 2002). Commonly in transformed cells the PI3K/Akt 
pathway is directly activated by the loss of PTEN, a negative regulator of PIP3 formation 
and an identified tumor suppressor. Maybe unsurprisingly in mES cells the role of PI3Ks 
was highlighted by the fact that in PTEN null mES cells, accelerated cell cycle progression 
was observed (Sun et al., 1999) which can be blocked by the PI3K inhibitor LY294002. 
However a role for PI3K signaling events has also been identified in the maintenance of 
pluripotency in mES cell derived for a number of species (Fig. 3) (Armstrong et al., 2006). 
Blocking PI3K signaling events results in elevated ERK/MAPK signaling (Paling et al., 2004) 
and there is evidence to suggest that ERK (Hamazaki et al., 2006) and Wnt (Sato et al., 2003) 
signaling are required to sustain pluripotency in both mouse and human ES cell lines. In the 
  
 
Fig. 3. Potential role for PI3K in self-renewal and LIF signaling in ES cells. 
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case of mES cells inhibition of PI3K pathways can induce differentiation in the presence or 
absence of LIF (Paling et al., 2004; Armstrong et al., 2006). However interestingly up 
regulation of Akt signaling is sufficient to maintain pluripotency of m ES cells (Watanabe et 
al., 2006). Another linkage for PI3K signaling and self-renewal comes from evidence that 
Nanog expression as well a number of Nanog target genes are modulated by PI3K signaling. 
Results have shown that the loss of pluripotent phenotype associated with PI3K blockage by 
LY294002 can be rescued by exogenous Nanog expression. Also regulation of GSK3 activity 
acting downstream of PI3Ks plays a role in Nanog expression. The evidence is clearly points 
out that PI3Ks play an important role in the signaling and maintenance of Nanog 
expression. PI3K effects are not limited directly to Nanog alone, inhibition of PI3K pathways 
results in the repression of rfx4, an identified Nanog target (Storm et al., 2007). However, 
interestingly, of the triad of master factors Oct4, Sox2, and Nanog, it appears that Nanog 
alone is sensitive to PI3K signaling pathways. However recently it has been shown that 
suppression of PI3K leads to a reduction in other self-renewal transcription factors including 
Klf4 (Storm et al., 2009), one of the targets in iPS generation. The role of PI3K in ES cells is 
complicated by the fact that self-renewal and cell proliferation are linked, and PI3Ks have 
been cast in major roles for both cellular processes. 
3.3 Wnt pathway 
The name “Wnt” comes from the fusion of the two names, int (based on the proto-oncogene 
integration-1 (Tanaka et al., 2002) and wg (based on wingless the segment polarity gene in 
Drosophila). The Wnt proteins are defined by amino acid sequence rather than by noted 
functional activities, but all Wnts share a number of common properties like numerous 
glycosylation sites and target sequences for secretion (Nusse and Varmus, 1992). Upon Wnt 
binding to its specific receptor, a signaling cascade is activated ultimately upregulating Wnt 
target genes. The Wnt signaling system is a highly conserved network controlling numerous 
other signaling transduction pathways from embryonic development to adult tissue 
homeostasis. Approximately 19 different WNT proteins have been identified acting on at 
least three different signaling pathways (Nusse and Varmus, 1992). The three pathways are 
the canonical Wnt pathway, acting via β-catenin and Tcf/Lef factors; the planar cell polarity 
(PCP) pathway; and the Wnt-Ca2þ pathway (Staal et al., 2008). This section will focus only 
on the canonical pathway. β-catenin is a well-known cytoplasmic protein and has a role in 
cell-cell adhesion acting to link membrane bound cadherins to the actin elements in the 
cytoskeleton. However it is now known to also act as a signaling molecule inside cells as 
part of the canonical Wnt signaling pathway (Reya and Clevers, 2005). In the absence of 
Wnt, β-catenin exists in a phosphorylated state in a complex marked for degradation by the 
ubiquitin-associated proteases. The β-catenin degradation complex includes the tumor 
suppressor proteins adenomatous polyposis coli gene (APC), Axin, and GSK3. Wnt 
signaling involves the Wnt ligand binding to the membrane receptor named Frizzled (Fz). 
Frizzled is a seven transmembrane receptor and the first receptor identified to bind the Wnt 
ligand (Bhanot et al., 1996). Activation of signal transduction by Wnt binding the Fz receptor 
requires a co-receptor attachment with a member of the low-density lipoprotein (LDL) 
family called Lrp5 and −6, this interaction is required for activation of the canonical Wnt 
signaling pathway (Li and Bu, 2005). Activation of Fz by Wnt results in the protection of β-
catenin from proteosomal degradation. Thus the action of Wnt is to maintain the 
intracellular levels of β-catenin which then translocates to the nucleus where it forms a 
transcription complex with one of a number of transcription factors including Tcf1, Tcf3, 
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Tcf4, or Lef1 (Okamura et al., 1998). Tcf1 is found mainly in T lymphocytes, Tcf4 is widely 
expressed and found in stem cells of gut while Tcf3 is expressed in mES cells. In mES cells 
there is growing but often-conflicting evidence that Wnt signaling pathways are important 
components of mES cell self-renewal. Wnt pathways have been shown to sustain 
pluripotency but also are important for of adult progenitor cell proliferation. The focus on 
Wnt signaling and its role in pluripotency comes from studies using the GSK3 inhibitor 5-
bromoindirubin-3-oxime (BIO) (Fig. 4) (Meijer et al., 2003; Sato et al., 2003).  
 
 
Fig. 4. Wnt signal pathway role in self-renewal. 
Inhibition of GSK3 prolongs the existence of β-catenin, causing it to accumulate, increasing 
the pool, which can translocate to the nucleus and activate gene expression. BIO has been 
shown to be able to maintain pluripotency of mouse and human ES cells in the absence of 
LIF (Sato et al., 2003). In a similar vain activation of Wnt signaling indirectly by removing 
the inhibitory effect of APC sustains pluripotency, suggesting the Wnt signaling is required 
for self-renewal (Kielman et al., 2002). In addition, treatment with Wnt3a was found to 
stimulate hES cell proliferation (Singla et al., 2006). Oct4 over-expression increased β-catenin 
transcriptional activity in progenitor cells. The Wnt controlled transcription factor Tcf3 has 
been shown to repress Nanog and thus promote differentiation. More recent studies have 
shown that Lef1 acting along with β-catenin is able to up-regulate Oct4 expression and 
interact with Nanog and thus promote self-renewal. All these data suggest that Wnt/β-
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catenin signaling has some role in the mES cell self-renewal (Takao et al., 2007). In obvious 
contrast to LIF and BMP signaling in mouse and human ES cells there is no difference 
between the cell types with regard to Wnt/β-catenin signaling self-renewal (Hao et al., 
2006). However, contrary to the above-portrayed role of Wnt in self-renewal, Wnt action has 
been shown to facilitate differentiation of mES cells into neural precursors and increases the 
expression of Brachyury a mesoderm marker (Yamaguchi et al., 1999). More work is 
required to elucidate the role of Wnt signaling in mES cell self-renewal and pluripotency 
and potential other effect for the non-canonical Wnt pathways. 
4. Summary and conclusion 
Even after prolonged periods and numerous expansions in culture ES cells retain the ability 
to respond to normal developmental signals and display no apparent bias for any one cell 
lineage when reintegrated to a developing embryo. Constructing a stable and coherent map 
of how ES cells achieve such a feat is a major challenge that must be met if the true potential 
of these cells is to be realized in a clinical setting. A fundamental breakthrough in this area 
came with the generation of a tetracycline-suppressible Oct4 transgene in late 2000. This 
study clearly defined the effect of Oct4 loss on ES cell self-renewal (Niwa et al., 2000). 
Silencing Oct4 resulted in ES cells differentiation into trophectoderm but most surprisingly 
an increase in Oct4 levels resulted in differentiation into mesoderm and endoderm cell 
linages (Niwa et al., 2000). Sox2 null ES cells differentiate into trophoectodermal type lineage 
(Masui et al., 2007). In the absence of Sox2 expression Oct/Sox targets were sustained, 
leading to the suggestion that other Sox proteins may replace the role of Sox2. Somewhat 
like Oct4 but less clear cut it would seem from over-expression studies in mES cells that up-
regulation of Sox2 results in formation of neural lineages (Kopp et al., 2008; Zhao et al., 
2004). Nanog was initially identified as a molecule capable of supporting the pluripotent 
phenotype of ES cells in the absence of LIF (Chambers et al., 2003). Suppression of Nanog 
results in increase differentiation (Chambers et al., 2007; Ivanova et al., 2006). Sufficient 
evidence indicates that the levels of Oct4, Sox2, and Nanog, govern to a large extent the 
pluripotency of ES cells (Chambers and Smith, 2004). Interestingly the accumulated work on 
these factors also points to the fact that Oct4 and Sox2 may perhaps drive a process of 
differentiation countering the self-renewal process. Oct4 and Sox2 increase the production of 
fibroblast growth factor 4 (FGF4), a growth factor that pushes ES cells toward differentiation 
by making them more susceptible to leverage by specific lineage commitment factors. All 
the while Nanog works to resist ES cells differentiation. Artificial high levels of Nanog 
through constitutive expression systems prevent ES cell differentiation even when FGF 
signaling is active (Chambers et al., 2003; Ying et al., 2003). However the true role of Nanog 
and its functional relationship to Oct4 and Sox2 is increasingly more complex. The level of 
Nanog found in individual normal ES cells shows a high degree of heterogeneity and Nanog 
knockouts can sustain self-renewal and are pluripotent (Chambers et al., 2007). In general 
though it appears that cells that are deficient in Nanog have a high propensity to 
differentiate (Chambers et al., 2007; Mitsui et al., 2003). Our understanding of the 
extracellular signaling interactions with these transcriptional networks is to date very 
unclear. The closest we are coming to tying these elements together is looking at work done 
on LIF signaling in ES cells. ES cells traditionally maintained on feeder cell layers in the 
presence of serum or a defined serum replacement with the addition of LIF for mouse, and 
bFGF for human ES cells. These less than wholly defined conditions are entirely problematic 
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for many reasons. A fundamental understanding of the pathways involved for both mouse 
and human stem cells is beginning to emerge. Niwa et al (2009) have shown that the LIF 
signaling is tightly linked into the transcriptional machinery of ES cell self-renewal. The 
Stat3 pathway activates Sox2 but not Nanog, while the PI3K–Akt pathway, effects 
predominately Nanog. Maintaining a pluripotent phenotype can be viewed as a getting the 
right balance between continued appropriate proliferation and inhibition of differentiation 
and/or cell death. Thus a key mechanism to sustaining ES cells in a pluripotent state may be 
to push and pull all at once i.e. push self-renewal factors and simultaneously block 
differentiation pathways. An example of this strategy is the effect of GSK3 inhibition in 
conjunction with inhibition of mitogen-activated protein kinase (MEK which facilitates long-
term self-renewal of mouse ES cells with no requirement for cytokines). As we get closer to 
understanding the pathways in mouse ES cells in particular the issue of difference in 
comparison to human lines become all the more apparent. Human ES cells are significantly 
different from mouse ES cells in phenotype and signaling pathway profiles. There is the 
suggestion that the human cell lines may represent a later stage (epiblast stage, Epi Stage 
Cells (EpiSCs)) of development compared to the mouse lines. LIF for example does not 
support either human ES cells or EpiSCs, but does support mES cell self-renewal (Xu et al., 
2005). Thus as we elucidate the pathways of pluripotency and self-renewal we will have to 
be mindful of the cells under study and the stage of development they represent. However 
these are not insurmountable tasks and growing volumes of data are beginning to delineate 
the signaling pathways and transcriptional networks controlling cell growth, proliferation 
and self-renewal. Only when we can clearly map the interactions of the many elements 
involved some competing and often conflicting signal pathways and key transcription 
regulators can we understand self-renewal and fully realise the potential of the pluripotent 
phenotype. 
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